| Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival TJ Curiel, G Coukos, L Zou, X Alvarez, P Cheng, P Mottram, ... Nature medicine 10 (9), 942-949, 2004 | 6251 | 2004 |
| Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity TJ Curiel, S Wei, H Dong, X Alvarez, P Cheng, P Mottram, R Krzysiek, ... Nature medicine 9 (5), 562-567, 2003 | 1538 | 2003 |
| Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV-and SIV-infected lymph nodes TH Finkel, G Tudor-Williams, NK Banda, MF Cotton, T Curiel, C Monks, ... Nature medicine 1 (2), 129-134, 1995 | 1163 | 1995 |
| B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma I Kryczek, L Zou, P Rodriguez, G Zhu, S Wei, P Mottram, M Brumlik, ... The Journal of experimental medicine 203 (4), 871-881, 2006 | 909 | 2006 |
| Safety and efficacy of durvalumab (MEDI4736), an anti–programmed cell death ligand-1 immune checkpoint inhibitor, in patients with advanced urothelial bladder cancer C Massard, MS Gordon, S Sharma, S Rafii, ZA Wainberg, J Luke, ... Journal of Clinical Oncology 34 (26), 3119, 2016 | 894 | 2016 |
| Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells W Zou, V Machelon, A Coulomb-L'Hermin, J Borvak, F Nome, T Isaeva, ... Nature medicine 7 (12), 1339-1346, 2001 | 806 | 2001 |
| Tregs and rethinking cancer immunotherapy TJ Curiel The Journal of clinical investigation 117 (5), 1167-1174, 2007 | 712 | 2007 |
| Interventions to slow aging in humans: are we ready? VD Longo, A Antebi, A Bartke, N Barzilai, HM Brown‐Borg, C Caruso, ... Aging cell 14 (4), 497-510, 2015 | 603 | 2015 |
| CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers I Kryczek, A Lange, P Mottram, X Alvarez, P Cheng, M Hogan, L Moons, ... Cancer research 65 (2), 465-472, 2005 | 570 | 2005 |
| Bone marrow is a reservoir for CD4+ CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals L Zou, B Barnett, H Safah, VF LaRussa, M Evdemon-Hogan, P Mottram, ... Cancer research 64 (22), 8451-8455, 2004 | 513 | 2004 |
| Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood … EJ Shpall, RB Jones, SI Bearman, WA Franklin, PG Archer, T Curiel, ... Journal of Clinical Oncology 12 (1), 28-36, 1994 | 484 | 1994 |
| Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma S Wei, I Kryczek, L Zou, B Daniel, P Cheng, P Mottram, T Curiel, A Lange, ... Cancer research 65 (12), 5020-5026, 2005 | 464 | 2005 |
| CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression D Jin, J Fan, L Wang, LF Thompson, A Liu, BJ Daniel, T Shin, TJ Curiel, ... Cancer research 70 (6), 2245-2255, 2010 | 456 | 2010 |
| Cross-talk in the innate immune system: neutrophils instruct recruitment and activation of dendritic cells during microbial infection S Bennouna, SK Bliss, TJ Curiel, EY Denkers The Journal of Immunology 171 (11), 6052-6058, 2003 | 455 | 2003 |
| Tumor-intrinsic PD-L1 signals regulate cell growth, pathogenesis, and autophagy in ovarian cancer and melanoma CA Clark, HB Gupta, G Sareddy, S Pandeswara, S Lao, B Yuan, ... Cancer research 76 (23), 6964-6974, 2016 | 363 | 2016 |
| Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer TJ Curiel, P Cheng, P Mottram, X Alvarez, L Moons, M Evdemon-Hogan, ... Cancer research 64 (16), 5535-5538, 2004 | 350 | 2004 |
| Regulatory T cells and treatment of cancer TJ Curiel Current opinion in immunology 20 (2), 241-246, 2008 | 326 | 2008 |
| Regulatory T cells in ovarian cancer: biology and therapeutic potential B Barnett, I Kryczek, P Cheng, W Zou, TJ Curiel American journal of reproductive immunology 54 (6), 369-377, 2005 | 304 | 2005 |
| Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC … D Mahalingam, M Mita, J Sarantopoulos, L Wood, RK Amaravadi, ... Autophagy 10 (8), 1403-1414, 2014 | 299 | 2014 |
| Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis PB Nash, MB Purner, RP Leon, P Clarke, RC Duke, TJ Curiel The Journal of Immunology 160 (4), 1824-1830, 1998 | 291 | 1998 |
